REGN vs SITE · P/E 14, rev $14.34B vs P/E 33, rev $4.70B
Regeneron Pharmaceuticals Inc (REGN) versus SiteOne Landscape Supply Inc (SITE) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
SiteOne Landscape Supply Inc (SITE) is a industrial distribution company listed on NYSE.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported SITE revenue for 2025-12-28 was $4.70B. Net income was $151.8M. Revenue was up 3.6% from 2024-12-29 to 2025-12-28. SITE currently screens at market cap $4.99B and trailing P/E 33.3.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. SITE currently screens at market cap $4.99B and trailing P/E 33.3.
Not investment advice. Open the REGN and SITE stock pages for the full models.
Not investment advice.